<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03220620</url>
  </required_header>
  <id_info>
    <org_study_id>A 2017-0073</org_study_id>
    <nct_id>NCT03220620</nct_id>
  </id_info>
  <brief_title>Influence of Perioperative Fluid Therapy on Hemoglobin and Methemoglobin Levels</brief_title>
  <official_title>Influence of Perioperative Fluid Therapy on Hemoglobin and Methemoglobin Levels in Major Abdominal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rostock</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rostock</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to evaluate influence of perioperative fluid therapy on
      Methemoglobin levels, and to changes in hemoglobin. Further, changes in Methemoglobin will be
      related to metabolic signs of oxidative stress (changes in blood lactate). Patients
      undergoing major abdominal surgery will be included into the study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Increasing plasma volume by intravenous administration of crystalloid and/or colloid
      solutions may cause a relative reduction in hemoglobin (Hb) concentration, a situation that
      is termed 'dilutional anemia'. Such hemodilution may lead to an iatrogenic reduction in
      oxygen-carrying capacity and the development of organ dysfunction. Paradoxically, large
      amounts of fluids that are administered with the aim of increasing oxygen delivery (DO2), as
      is frequently done as part of perioperative goal-directed therapy; this may lead to an actual
      decrease in the DO2 due to a decrease in Hb concentration.

      Another potential parameter that may reflect the development of dilutional anemia is
      methemoglobin (MetHb), a form of Hb with reduced ability for oxygen binding. Experimental
      studies showed that dilutional anemia may lead to up-regulation of perivascular nitric oxide
      synthase (NOS) and increase NOS-derived nitric oxide (NO) leading to local vasodilation and
      oxidization of Hb to MetHb. MetHb may potentially serve as a biomarker of 'anemic stress'
      associated with reduced tissue perfusion during acute hemodilution.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 14, 2017</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Influence of perioperative fluid therapy on hemoglobin levels</measure>
    <time_frame>during surgery</time_frame>
    <description>Influence of perioperative fluid therapy on hemoglobin levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Influence of perioperative fluid therapy on Methemoglobin levels</measure>
    <time_frame>during surgery</time_frame>
    <description>Influence of perioperative fluid therapy on Methemoglobin levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Influence of perioperative fluid therapy on changes in lactate</measure>
    <time_frame>during surgery</time_frame>
    <description>Influence of perioperative fluid therapy on changes in lactate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence of perioperative fluid therapy on SvO2</measure>
    <time_frame>during surgery</time_frame>
    <description>Influence of perioperative fluid therapy on SvO2</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Perioperative/Postoperative Complications</condition>
  <condition>Fluid Overload</condition>
  <condition>Hemoglobin H</condition>
  <arm_group>
    <arm_group_label>GDT Group</arm_group_label>
    <description>receives goal-directed therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Not GDT Group</arm_group_label>
    <description>receives no individualized goal-directed therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>GDT</intervention_name>
    <description>individualized fluid therapy</description>
    <arm_group_label>GDT Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing major abdominal surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  major abdominal surgery

          -  informed consent

        Exclusion Criteria:

          -  violation of study protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Mencke, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rostock</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Mencke, Prof.</last_name>
    <phone>+49381 494 6411</phone>
    <email>thomas.mencke@uni-rostock.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amelie Zitzmann, Dr.</last_name>
    <phone>+49381 4946411</phone>
    <email>amelie.zitzmann@med.uni-rostock.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Rostock</name>
      <address>
        <city>Rostock</city>
        <state>Mecklenburg/Vorpommern</state>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Mencke, Prof.</last_name>
      <phone>+49381 4946411</phone>
      <email>thomas.mencke@uni-rostock.de</email>
    </contact>
    <contact_backup>
      <last_name>Amelie Zitzmann, Dr.</last_name>
      <phone>+49381 4946411</phone>
      <email>amelie.zitzmann@med.uni-rostock.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2017</study_first_submitted>
  <study_first_submitted_qc>July 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2017</study_first_posted>
  <last_update_submitted>August 10, 2017</last_update_submitted>
  <last_update_submitted_qc>August 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rostock</investigator_affiliation>
    <investigator_full_name>Thomas Mencke</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>fluid therapy</keyword>
  <keyword>perioperative</keyword>
  <keyword>hemodilution</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

